Medication in the treatment of alcohol dependence
Open Access
- 1 November 1996
- journal article
- Published by Cambridge University Press (CUP) in Advances in Psychiatric Treatment
- Vol. 2 (6) , 249-257
- https://doi.org/10.1192/apt.2.6.249
Abstract
Social, cultural, emotional and biological influences determine whether people drink to excess and whether they then experience harm or cause harm to others (Cook, 1994). Psychosocial treatments for alcohol dependence are only modestly successful, with most studies finding that at least 50% of patients return to harmful drinking in the following year. In the past decade there has been new evidence for the role of pharmacological treatments in reducing harm from drinking and in preventing relapse.Keywords
This publication has 16 references indexed in Scilit:
- Enhanced Sensitivity of Pituitary βEndorphin to Ethanol in Subjects at High Risk of AlcoholismArchives of General Psychiatry, 1996
- Addiction: brain mechanisms and their treatment implicationsThe Lancet, 1996
- A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol DependenceAlcohol, Clinical and Experimental Research, 1994
- A Meta-Analysis of Fluoxetine Outcome in the Treatment of DepressionJournal of Nervous & Mental Disease, 1994
- Buspirone Treatment of Anxious AlcoholicsArchives of General Psychiatry, 1994
- A Placebo‐Controlled Trial of Buspirone in Anxious Inpatient AlcoholicsAlcohol, Clinical and Experimental Research, 1992
- Disulfiram Treatment of AlcoholismThe British Journal of Psychiatry, 1992
- Reversible, late‐onset disulfiram‐induced neuropathy and encephalopathyAnnals of Neurology, 1985
- A reappraisal of alcoholic psychosesPsychological Medicine, 1978